List of Major Drug Patent Expirations Happening in 2019
With every year that passes, more and more brand drug patent expirations occur. This year is no different. Some major drugs will lose patent protections in 2019, paving the way for generic alternatives and lower prices.
The patents for medications typically last for around 20 years after the initial application date. Patent protection can vary by how the drug is marketed. For example, a drug may lose its patent protection for certain treatments, but may maintain it for a longer period of time when it relates to other treatments.
Updated on January 24, 2019, based on this list of drug patent expirations.
Here are the major drug patent expirations for 2019
SYMLIN
Generic name: pramlintide acetate
Patent Expiration / Generic Entry Opportunity: March 16, 2019
Use: Symlin can help control blood sugar in people with diabetes. It’s always used with insulin.
TECFIDERA
Generic name: dimethyl fumarate
Patent Expiration / Generic Entry Opportunity: April 01, 2019
Use: Tecfidera is a fumaric acid ester used to treat relapsing forms of multiple sclerosis (MS).
FLECTOR
Generic name: diclofenac epolamine
Patent Expiration / Generic Entry Opportunity: April 13, 2019
Use: Flector can be used as a pain reliever indicated for the topical treatment of acute pain due to minor strains, sprains and contusions.
CETROTIDE
Generic name: cetrorelix
Patent Expiration / Generic Entry Opportunity: April 23, 2019
Use: Cetrotide can prevent premature ovulation in women undergoing fertility treatments with controlled ovulation.
OMTRYG
Generic name: omega-3-acid ethyl esters type a
Patent Expiration / Generic Entry Opportunity: April 23, 2019
Use: Omtryg are used together with diet and exercise to help lower triglyceride levels in the blood.
BEVESPI AEROSPHERE
Generic name: formoterol fumarate; glycopyrrolate
Patent Expiration / Generic Entry Opportunity: April 25, 2019
Use: Bevespi Aerosphere works two ways to help open airways and keep them open.
OTOVEL
Generic name: ciprofloxacin hydrochloride; fluocinolone acetonide
Patent Expiration / Generic Entry Opportunity: April 29, 2019
Use: Otovel is used to treat a type of middle ear infection in children called acute otitis media with tympanostomy tubes (AOMT) caused by certain bacteria.
BYVALSON
Generic name: nebivolol hydrochloride; valsartan
Patent Expiration / Generic Entry Opportunity: June 3, 2019
Use: Byvalson (Nebivolol & Valsartan) is a combination medicine used to treat high blood pressure (hypertension) in adults.
RESCRIPTOR
Generic name: delavirdine mesylate
Patent Expiration / Generic Entry Opportunity: June 7, 2019
Use: Rescriptor can treat HIV, the infection that causes AIDS. It doesn’t cure HIV or AIDS, but combinations of drugs that treat HIV infection may slow the disease progress and prolong life.
NATROBA
Generic name: spinosad
Patent Expiration / Generic Entry Opportunity: June 22, 2019
Use: Natroba topical suspension is used to treat head lice in adults and children who are at least 6 months old.
KOVANAZE
Generic name: oxymetazoline hydrochloride; tetracaine hydrochloride
Patent Expiration / Generic Entry Opportunity: June 29, 2019
Use: Kovanaze is a nasal spray used as dental anesthesia.
FIRAZYR
Generic name: icatibant acetate
Patent Expiration / Generic Entry Opportunity: July 15, 2019
Use: Firazyr can treat sudden attacks of hereditary angioedema (HAE).
NOXAFIL
Generic name: posaconazole
Patent Expiration / Generic Entry Opportunity: July 19, 2019
Use: Noxafil can treat or prevent fungal infections, especially in people with weak immune systems.
CARDIOTEC
Generic name: Folic Acid-C-B6-B12-E-Arginine
Patent Expiration / Generic Entry Opportunity: July 28, 2019
Use: Cardiotec is used for nutritional support and dietary supplementation.
TROXYCA ER
Generic name: naltrexone hydrochloride; oxycodone hydrochloride
Patent Expiration / Generic Entry Opportunity: August 19, 2019
Use: Troxyca ER is an extended release capsule formulation of oxycodone combined with naltrexone.
YOSPRALA
Generic name: aspirin; omeprazole
Patent Expiration / Generic Entry Opportunity: September 14, 2019
Use: Yosprala is a prescription medicine used in people who have had heart problems or strokes caused by blood clots, to help reduce their risk of further heart problems or strokes, and who are at risk of developing stomach ulcers with aspirin.
CYSTARAN
Generic name: cysteamine hydrochloride
Patent Expiration / Generic Entry Opportunity: October 2, 2019
Use: Cystaran can prevent the buildup of cystine crystals in the kidneys in its oral form. Other forms can treat cystine crystal buildup in the eye (cystinosis).
LUMASON
Generic name: sulfur hexafluoride lipid-type a microspheres
Patent Expiration / Generic Entry Opportunity: October 10, 2019
Use: Lumason (sulfur hexafluoride lipid-type A microspheres) is an ultrasound contrast agent indicated for use in echocardiography to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border in adult patients with suboptimal echocardiograms, and in ultrasonography of the liver for characterization of focal liver lesions in adult and pediatric patients.
SYNRIBO
Generic name: omacetaxine mepesuccinate
Patent Expiration / Generic Entry Opportunity: October 26, 2019
Use: Synribo is used for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia.
IONSYS
Generic name: fentanyl hydrochloride
Patent Expiration / Generic Entry Opportunity: November 02, 2019
Use: Ionsys is used to treat severe pain.
SIMBRINZA
Generic name: brimonidine tartrate; brinzolamide
Patent Expiration / Generic Entry Opportunity: December 13, 2019
Use: Brimonidine and brinzolamide ophthalmic can reduce the amount of fluid in the eye, which decreases pressure inside the eye.
DUREZOL
Generic name: difluprednate
Patent Expiration / Generic Entry Opportunity: July 19, 2019
Use: Durezol can treat eye irritation and inflammation.
RxSaver Editors
RxSaver Editors are wellness enthusiasts who help you learn how you can save the most on prescription medication costs and other health-related topics.
The information on this site is generalized and is not medical advice. It is intended to supplement, not substitute for, the expertise and judgment of your healthcare professional. Always seek the advice of your healthcare professional with any questions you may have regarding a medical condition. Never disregard seeking advice or delay in seeking treatment because of something you have read on our site. RxSaver makes no warranty as to the accuracy, reliability or completeness of this information.
If you are in crisis or you think you may have a medical emergency, call your doctor or 911 immediately.
READ MORE
Best Practices for Going Back to School During COVID-19
Key takeaways: For children and teens age 12 and up, COVID vaccines provide the best protection against COVID-19. Universal masking is the best...
By David Hill, MD, FAAP
Americans Weigh In on Mental Health, Vaccines and Anxieties Over New Normal In Latest Study
A year later we are entering a new normal, multiple COVID-19 vaccinations are available, and Americans are beginning to see a light at the end of the
By Bre D’Alessio South
What to Know About Schools Reopening During the COVID-19 Pandemic
Key takeaways: Reopening schools safely relies on having limited COVID-19 spread in the community. The CDC recommends universal masking and...
By Angela Dunn, MD, MPH